HHLR ADVISORS LTD. 13D and 13G filings for Kiniksa Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:08 pm Sale |
2022-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
HHLR ADVISORS LTD. | 2,623,924 7.600% |
-296,099 (-10.14%) |
Filing |
| 2021-02-16 4:24 pm Purchase |
2020-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
HHLR ADVISORS LTD. | 2,920,023 9.200% |
1,024,135 (+54.02%) |
Filing |